ArticleFrontiers in pharmacology2023
Case report: the dissociated response and clinical benefit of primary leiomyosarcoma of the bone treated with penpulimab plus lenvatinib after failed multi-line therapy.
Bin Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.